Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda
Authors:
- Heidi AlbertHAHeidi Albert
- Freddie BwangaFBFreddie Bwanga
- Sheena MukkadaSMSheena Mukkada
- Barnabas NyesigaBNBarnabas Nyesiga
- Julius Patrick AdemunJAJulius Patrick Ademun
- George LukyamuziGLGeorge Lukyamuzi
- Melles HaileMHMelles Haile
- Sven HoffnerSHSven Hoffner
- Moses JolobaMJMoses Joloba
- Richard O'BrienRORichard O'Brien
Open Access
- 26 February 2010
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 10 (1) , 41
Abstract
About 500 new smear-positive Multidrug-resistant tuberculosis (MDR-TB) cases are estimated to occur per year in Uganda. In 2008 in Kampala, MDR-TB prevalence was reported as 1.0% and 12.3% in new and previously treated TB cases respectively. Line probe assays (LPAs) have been recently approved for use in low income settings and can be used to screen smear-positive sputum specimens for resistance to rifampicin and isoniazid in 1-2 days.Keywords
This publication has 8 references indexed in Scilit:
- GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysisEuropean Respiratory Journal, 2008
- Rapid Molecular Screening for Multidrug-Resistant Tuberculosis in a High-Volume Public Health Laboratory in South AfricaAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changesThe Lancet, 2007
- Molecular Analysis of Isoniazid-Resistant Mycobacterium tuberculosis Isolates from England and Wales Reveals the Phylogenetic Significance of the ahpC −46A PolymorphismAntimicrobial Agents and Chemotherapy, 2005
- High Prevalence of KatG Ser315Thr Substitution among Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates from Northwestern Russia, 1996 to 2001Antimicrobial Agents and Chemotherapy, 2002
- Analysis for a Limited Number of Gene Codons Can Predict Drug Resistance of Mycobacterium tuberculosis in a High-Incidence CommunityJournal of Clinical Microbiology, 2001
- Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilliThe Lancet, 1999
- Detection of rifampicin-resistance mutations in Mycobacterium tuberculosisThe Lancet, 1993